Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,195 | 210 | 98.7% |
| Education | $41.16 | 3 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $595.63 | 37 | $0 (2024) |
| PFIZER INC. | $354.17 | 31 | $0 (2024) |
| Myovant Sciences Inc. | $279.52 | 11 | $0 (2022) |
| Allergan, Inc. | $226.89 | 15 | $0 (2020) |
| Exeltis, USA Inc. | $223.32 | 17 | $0 (2024) |
| Astellas Pharma US Inc | $182.74 | 11 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $153.61 | 9 | $0 (2024) |
| Daiichi Sankyo Inc. | $151.31 | 10 | $0 (2023) |
| Amgen Inc. | $118.59 | 9 | $0 (2020) |
| TherapeuticsMD, Inc. | $101.23 | 7 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $293.09 | 17 | Sumitomo Pharma America, Inc. ($76.69) |
| 2023 | $294.58 | 18 | Sumitomo Pharma America, Inc. ($76.92) |
| 2022 | $680.49 | 34 | ABBVIE INC. ($229.61) |
| 2021 | $438.78 | 30 | Exeltis, USA Inc. ($113.21) |
| 2020 | $250.03 | 19 | AbbVie Inc. ($67.13) |
| 2019 | $389.77 | 28 | AbbVie, Inc. ($74.94) |
| 2018 | $514.21 | 42 | PFIZER INC. ($109.72) |
| 2017 | $375.18 | 25 | PFIZER INC. ($82.29) |
All Payment Transactions
213 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: HORMONE THERAPY | ||||||
| 11/21/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $17.87 | General |
| Category: CONTRACEPTIVE | ||||||
| 10/09/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: HORMONE THERAPY | ||||||
| 10/01/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: Biological | ||||||
| 09/12/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: CONTRACEPTIVE | ||||||
| 08/28/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: HORMONE THERAPY | ||||||
| 07/25/2024 | PFIZER INC. | PREMARIN (Drug), ESTRING, DUAVEE | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: WOMENS HEALTH | ||||||
| 07/23/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.20 | General |
| Category: Biological | ||||||
| 06/27/2024 | Evofem Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $19.96 | General |
| 06/18/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: HORMONE THERAPY | ||||||
| 05/02/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: NEUROSCIENCE | ||||||
| 04/25/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: HORMONE THERAPY | ||||||
| 04/16/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: VACCINE | ||||||
| 03/21/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), GARDASIL 9 | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: VACCINE | ||||||
| 02/29/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: ETONOGESTREL | ||||||
| 01/18/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: Biological | ||||||
| 01/04/2024 | Hologic Sales and Service, LLC | APTIMA (Device) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: Diagnostics | ||||||
| 12/14/2023 | Agile Therapeutics, Inc. | Twirla (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Birth Control Contraceptive Patch | ||||||
| 12/12/2023 | Hologic Sales and Service, LLC | APTIMA (Device) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: Diagnostics | ||||||
| 12/06/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: HORMONE THERAPY | ||||||
| 10/24/2023 | AbbVie Inc. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: WOMENS HEALTH | ||||||
| 10/18/2023 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $14.48 | General |
| 10/13/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Biological | ||||||
| 08/11/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: HORMONE THERAPY | ||||||
| 07/30/2023 | AbbVie Inc. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: WOMENS HEALTH | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 219 | 230 | $88,797 | $12,376 |
| 2022 | 5 | 164 | 177 | $83,934 | $11,197 |
| 2021 | 5 | 195 | 214 | $96,741 | $13,111 |
| 2020 | 4 | 222 | 256 | $36,256 | $13,957 |
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 92 | 92 | $23,996 | $3,836 | 16.0% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 81 | 81 | $23,821 | $3,809 | 16.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 21 | 29 | $24,504 | $2,737 | 11.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 25 | 28 | $16,476 | $1,994 | 12.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 27 | 32 | $27,010 | $3,274 | 12.1% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 70 | 70 | $18,424 | $3,012 | 16.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 29 | 37 | $22,184 | $2,465 | 11.1% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 26 | 26 | $7,448 | $1,269 | 17.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 12 | 12 | $8,868 | $1,177 | 13.3% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 62 | 62 | $21,709 | $3,060 | 14.1% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 65 | 65 | $18,789 | $2,865 | 15.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 18 | 26 | $21,407 | $2,652 | 12.4% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 25 | 34 | $20,698 | $2,614 | 12.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 25 | 27 | $14,138 | $1,921 | 13.6% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2020 | 75 | 75 | $9,750 | $3,631 | 37.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 42 | 63 | $9,009 | $3,598 | 39.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 32 | 45 | $9,540 | $3,483 | 36.5% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 73 | 73 | $7,957 | $3,246 | 40.8% |
About Dr. Gary Brickner, MD
Dr. Gary Brickner, MD is a Obstetrics & Gynecology healthcare provider based in Hamilton, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1699796607.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Brickner, MD has received a total of $3,236 in payments from pharmaceutical and medical device companies, with $293.09 received in 2024. These payments were reported across 213 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($3,195).
As a Medicare-enrolled provider, Brickner has provided services to 800 Medicare beneficiaries, totaling 877 services with total Medicare billing of $50,641. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Practice Information
- Specialty Obstetrics & Gynecology
- Location Hamilton, NJ
- Active Since 07/22/2006
- Last Updated 12/19/2011
- Taxonomy Code 207V00000X
- Entity Type Individual
- NPI Number 1699796607
Products in Payments
- MYFEMBREE (Drug) $433.13
- LO LOESTRIN FE (Drug) $401.69
- ORILISSA (Drug) $255.37
- PREMARIN (Drug) $219.32
- SLYND (Drug) $193.07
- INJECTAFER (Drug) $151.31
- Prolia (Biological) $107.60
- PREMARIN ORALS (Drug) $89.77
- Orilissa (Drug) $84.70
- Veozah (Drug) $79.18
- Kyleena (Drug) $64.74
- Balcoltra (Drug) $64.31
- Myrbetriq (Drug) $60.27
- IMVEXXY (Drug) $58.51
- INTRAROSA (Drug) $55.93
- SOLOSEC (Drug) $48.29
- Phexxi (Drug) $45.98
- TRUCLEAR (Device) $45.09
- PVC (Drug) $45.08
- APTIMA (Device) $40.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Obstetrics & Gynecology Doctors in Hamilton
Andrew Chang, Md, MD
Obstetrics & Gynecology — Payments: $9,448
Mary Camden, Md, MD
Obstetrics & Gynecology — Payments: $8,442
Dr. Robert Mayson, Md, MD
Obstetrics & Gynecology — Payments: $4,641
Cary Mantell, Do, DO
Obstetrics & Gynecology — Payments: $3,774
James Zubernis, Do, DO
Obstetrics & Gynecology — Payments: $3,594
Dr. Kelly Risner, M.d, M.D
Obstetrics & Gynecology — Payments: $1,306